
    
      The study is designed to compare renal toxicity of Iodixanol and Iopromide after coronary
      angiography or percutaneous coronary intervention (PCI) in patient with Chronic Kidney
      Disease, considering original renal function and adequate hydration. The risk of varying
      degree of renal impairment, changes of serum Cys C level will also be evaluated.
    
  